MART-1 antigen [clinicaltrials_resource:204341fc300ac8b1aed380075968e1a7]
Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00003792]Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00005841]Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00006113]Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00006385]Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma [clinicaltrials:NCT00010309]Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00019214]Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00019721]Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00019994]Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery [clinicaltrials:NCT00025181]Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma [clinicaltrials:NCT00031733]Vaccine Therapy in Treating Patients With Melanoma of the Eye [clinicaltrials:NCT00036816]Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma [clinicaltrials:NCT00037037]Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00091338]LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery [clinicaltrials:NCT00295958]Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00334776]
intervention [clinicaltrials_vocabulary:intervention]
MART-1 antigen [clinicaltrials_resource:204341fc300ac8b1aed380075968e1a7]
Bio2RDF identifier
204341fc300ac8b1aed380075968e1a7
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:204341fc300ac8b1aed380075968e1a7
intervention name [clinicaltrials_vocabulary:intervention-name]
MART-1 antigen
identifier
clinicaltrials_resource:204341fc300ac8b1aed380075968e1a7
title
MART-1 antigen
@en
type
label
MART-1 antigen [clinicaltrials_resource:204341fc300ac8b1aed380075968e1a7]
@en